These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16562603)

  • 1. [Clinical and genetics aspects of Alport syndrome].
    Golshayan D; Venetz JP; Cachat F; Fellmann F; Moll S; Burnier M; Barbey F
    Rev Med Suisse; 2006 Mar; 2(55):593-8. PubMed ID: 16562603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of type IV collagen subchains in the glomerular basement membrane of patients with Alport syndrome with confocal microscopy.
    Su J; Liu ZH; Zeng CH; Wei-Gong ; Chen HP; Li LS
    Nephrol Dial Transplant; 2006 Jul; 21(7):1838-47. PubMed ID: 16574687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alport syndrome and thin basement membrane nephropathy.
    Thorner PS
    Nephron Clin Pract; 2007; 106(2):c82-8. PubMed ID: 17570934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
    Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
    J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and genetic features of the Alport 'syndromes'].
    Pescucci C; Longo I; Mari F; Scala E; Bruttini M; Caselli R; Renieri A
    G Ital Nefrol; 2005; 22(5):466-76. PubMed ID: 16267804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Collagen IV (alpha3-alpha4) nephropathy].
    Torra R; Tazón B; Ars E; Ballarín J
    Nefrologia; 2005; 25 Suppl 2():29-32. PubMed ID: 16050399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
    Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
    Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated transfer of type IV collagen alpha5 chain cDNA into swine kidney in vivo: deposition of the protein into the glomerular basement membrane.
    Heikkilä P; Tibell A; Morita T; Chen Y; Wu G; Sado Y; Ninomiya Y; Pettersson E; Tryggvason K
    Gene Ther; 2001 Jun; 8(11):882-90. PubMed ID: 11423936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alport syndrome or progressive hereditary nephritis with hearing loss].
    Gubler MC; Heidet L; Antignac C
    Nephrol Ther; 2007 Jun; 3(3):113-20. PubMed ID: 17540313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
    Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F
    Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renal lesions of Alport syndrome.
    Heidet L; Gubler MC
    J Am Soc Nephrol; 2009 Jun; 20(6):1210-5. PubMed ID: 19470679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
    Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
    J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
    Wilson JC; Yoon HS; Walker RJ; Eccles MR
    Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of assembly of recombinant type IV collagen alpha3, alpha4, and alpha5 chains in transfected cell strains.
    Kobayashi T; Uchiyama M
    Kidney Int; 2003 Dec; 64(6):1986-96. PubMed ID: 14633121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal dominant nephritis with renal failure of non-Alport type: clinical and molecular studies.
    Ilan T; Shohat T; Tobar A; Magal N; Yahav M; Halpern GJ; Rechavi G; Shohat M
    Isr Med Assoc J; 2001 Jul; 3(7):488-91. PubMed ID: 11791413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular basement membrane. Identification of a novel disulfide-cross-linked network of alpha3, alpha4, and alpha5 chains of type IV collagen and its implications for the pathogenesis of Alport syndrome.
    Gunwar S; Ballester F; Noelken ME; Sado Y; Ninomiya Y; Hudson BG
    J Biol Chem; 1998 Apr; 273(15):8767-75. PubMed ID: 9535854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of type IV collagen in the cochlea in Alport syndrome.
    Zehnder AF; Adams JC; Santi PA; Kristiansen AG; Wacharasindhu C; Mann S; Kalluri R; Gregory MC; Kashtan CE; Merchant SN
    Arch Otolaryngol Head Neck Surg; 2005 Nov; 131(11):1007-13. PubMed ID: 16301374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alport syndrome in the light of current molecular genetics].
    Pirson Y
    Bull Mem Acad R Med Belg; 1996; 151(10-11):447-52; discussion 452-3. PubMed ID: 9491622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Collagen alpha5 and alpha2 (IV) chain coexpression: The procedure of choice to diagnose Alport syndrome from skin biopsies].
    Patey-Mariaud de Serre N; Noël LH
    Ann Pathol; 2008 Jun; 28(3):182-6. PubMed ID: 18706356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.